Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1021/acsinfecdis.1c00079 http://scihub22266oqcxt.onion/10.1021/acsinfecdis.1c00079 33683857!ä!33683857 Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33683857&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       ACS+Infect+Dis 2021 ; 7 (4): 693-694 Nephropedia Template TP {{tp|p=33683857|t=2021. Learning from COVID-19 to Tackle Antibiotic Resistance |pdf=|usr=}}{{33683857}} gab.com Text Learning from COVID-19 to Tackle Antibiotic Resistance JO: ACS Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=33683857 #FOAvip COVID-19 has brought into sharp focus the failure of not preventing and preparing for pandemics. As the world reels from the tragedy and economic fallout of COVID-19, there are vital lessons to learn and apply in the fight against drug resistance. The unchecked growth of drug-resistant infections is a silent pandemic with long-term implications for global public health and the global economy. Now more than ever, governments have the opportunity to make robust and comprehensive investments into the way they prepare and respond to antibiotic resistance. This could cascade into lasting and long-term benefits for people and countries. Twit Text FOAVip Learning from COVID-19 to Tackle Antibiotic Resistance ????ACS Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=33683857 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33683857 #FOAvip English Wikipedia <ref>{{Cite pmid|33683857}}</ref> Learning from COVID-19 to Tackle Antibiotic Resistance #MMPMID33683857 Balasegaram M ACS Infect Dis 2021[Apr]; 7 (4): 693-694 PMID33683857show ga COVID-19 has brought into sharp focus the failure of not preventing and preparing for pandemics. As the world reels from the tragedy and economic fallout of COVID-19, there are vital lessons to learn and apply in the fight against drug resistance. The unchecked growth of drug-resistant infections is a silent pandemic with long-term implications for global public health and the global economy. Now more than ever, governments have the opportunity to make robust and comprehensive investments into the way they prepare and respond to antibiotic resistance. This could cascade into lasting and long-term benefits for people and countries. |*COVID-19[MESH] |*Drug Resistance, Microbial[MESH] |Global Health[MESH] |Humans[MESH]Learning from COVID-19 to Tackle Antibiotic Resistance (epmc).pdf DeepDyve Pubget Overpricing